Agape ATP Corporation, an investment holding company, provides health and wellness products and health solution advisory services in Malaysia.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$8.00|
|52 Week High||US$8.00|
|52 Week Low||US$8.00|
|1 Month Change||n/a|
|3 Month Change||n/a|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||33.33%|
Recent News & Updates
|AATP||US Healthcare||US Market|
Return vs Industry: Insufficient data to determine how AATP performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how AATP performed against the US Market.
Stable Share Price: Insufficient data to determine AATP's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine AATP's volatility change over the past year.
About the Company
Agape ATP Corporation, an investment holding company, provides health and wellness products and health solution advisory services in Malaysia. The company offers three series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE names. Its products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP2 Energized Mineral Concentrate, a nutritional supplement, which supports and enhances nutritional biochemical activities; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1 Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Is Agape ATP undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: AATP ($8) is trading above our estimate of fair value ($0.01)
Significantly Below Fair Value: AATP is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: AATP is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: AATP is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AATP's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AATP is overvalued based on its PB Ratio (618.2x) compared to the US Healthcare industry average (3.3x).
How is Agape ATP forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Agape ATP has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Agape ATP performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AATP is currently unprofitable.
Growing Profit Margin: AATP is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AATP is unprofitable, but has reduced losses over the past 5 years at a rate of 1.6% per year.
Accelerating Growth: Unable to compare AATP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AATP is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.2%).
Return on Equity
High ROE: AATP has a negative Return on Equity (-9.78%), as it is currently unprofitable.
How is Agape ATP's financial position?
Financial Position Analysis
Short Term Liabilities: AATP's short term assets ($4.6M) exceed its short term liabilities ($860.4K).
Long Term Liabilities: AATP's short term assets ($4.6M) exceed its long term liabilities ($157.4K).
Debt to Equity History and Analysis
Debt Level: AATP is debt free.
Reducing Debt: AATP had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable AATP has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: AATP is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 22.9% per year.
What is Agape ATP current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AATP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AATP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AATP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AATP's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AATP's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David How (57 yo)
Mr. Kok Choong How also known as David, has been the Global Chief Executive Officer, President, Secretary, Treasurer and Director of Agape ATP Corporation since June 1, 2016. Mr. How served as the Chairman...
Experienced Management: AATP's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Agape ATP Corporation's employee growth, exchange listings and data sources
- Name: Agape ATP Corporation
- Ticker: AATP
- Exchange: OTCPK
- Founded: 2016
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$3.012b
- Shares outstanding: 376.45m
- Website: https://www.agapeatpgroup.com
Number of Employees
- Agape ATP Corporation
- 1705 – 1708, Faber Towers
- Tower 2, Level 17
- Kuala Lumpur
- Wilayah Persekutuan
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/16 22:12|
|End of Day Share Price||2021/09/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.